Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

EONS13: Quality and safety of cancer nursing

CN21 - Patient and occupational safety in Europe: A survey by the European Oncology Nursing Society

Date

21 Sep 2020

Session

EONS13: Quality and safety of cancer nursing

Topics

COVID-19 and Cancer

Tumour Site

Presenters

Helena Ullgren

Citation

Annals of Oncology (2020) 31 (suppl_4): S1073-S1074. 10.1016/annonc/annonc315

Authors

H. Ullgren1, L. Sharp2, M.N. Fowler3, F. Conceicao4, P. Crombez5, H. Hálfdánardóttir6, A. Khmaladze7, D. Protogiros8, T.A. Theologia9, M. van Klinken10

Author affiliations

  • 1 Theme Cancer/ Regional Cancer Center, Karolinska University Hospital-Solna, 171 76 - Solna/SE
  • 2 Innovative Care, Lime, Karolinska Institute, Stockholm/SE
  • 3 Nhsft, Heartlands Hospital-Heart of England NHS Foundation Trust, B9 5SS - Birmingham/GB
  • 4 Surgery, Champalimaud Foundation, 1500-038 - Lisboa/PT
  • 5 Hematology, Institute Jules Bordet, 1000 - Brussels/BE
  • 6 Icelandic Cancer Institute, Icelandic Cancer Institute, Reijkavik/IS
  • 7 Nursing, Tbilisi Cancer Center, Tbilisi/GE
  • 8 Public Health, Hellenic Public Health Organisation, 21 - Athens/GR
  • 9 Nursing Department, Cyprus University of Technology - Nursing Science, 3041 - Limassol/CY
  • 10 Netherlands Cancer Institute, Netherlands Cancer Institute, Amsterdam/NL

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract CN21

Background

Cancer nurses have a crucial role in safe administration, management and delivery of cancer care. Guidelines, education and access to Personal Protective Equipment (PPE) vary between countries and healthcare organizations. European Oncology Nursing Society’s (EONS) Advocacy working group, set a strategic goal to raise awareness on patient safety. To gain knowledge on both patient- and occupational safety from European cancer nurses, a survey was conducted.

Methods

EONS Advocacy working group developed a survey on occupational and patient safety. The semi-structured survey consists of two parts; one with 20 items on occupational safety (with the option of free-text comments) and one validated tool (Hospital Survey on patient safety (HSPS), not analyzed here). The survey (translated into 8 languages) was anonymous and handed out at various national cancer nursing conferences, at EONS cancer nursing conference 2019 and online via EONS webpage (from October 2019 and onwards). A database was developed by the Regional Cancer Centre in Stockholm-Gotland, Sweden, dedicated for this survey. Quantitative and qualitative analysis methods were used to present the preliminary data findings. The survey will be open until August 2020.

Results

To date 491 cancer nurses from 38 European countries have responded. Preliminary analysis indicates differences between countries and institutions. Guidelines on management and administration of cytotoxic drugs is frequently reported, but these guidelines are not fully implemented and often not followed due to “pressure at work”, “lack of training”, “lack of knowledge of health and safety risks” and “peer pressure”. Free-text responses highlight a number of safety related issues experienced by the nurses, and lack of support by organization and/or managers to follow and implement safe work processes.

Conclusions

Preliminary results indicate several challenges and areas for improvement in occupational and patient safety in Europe. Current practices and exposures suggest risk that is not acceptable. There is a need for a minimum standard practice regarding education and PPE on a European level and cancer nurses must be involved in the process.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.